|

Shared Decision Making in Melanoma Patients Receiving Adjuvant Therapy

RECRUITINGSponsored by Odense University Hospital
Actively Recruiting
SponsorOdense University Hospital
Started2022-03-01
Est. completion2024-12-30
Eligibility
Age18 Years – 100 Years
View on ClinicalTrials.gov →

NCT06294379

Summary

This study aims to develop test and evaluate a Patient Decision Aid called "The Decision Helper" among melanoma patients eligible for adjuvant treatment. * Is the Decision Helper an acceptable tool for patients and clinicians and is it feasible in clinical practice? * Are there any differences in the levels of decisional regret in the patients who have not used the Decision Helper (pre-implementation) compared to the ones who have (post-implementation?

Eligibility

Age: 18 Years – 100 Years
Inclusion Criteria:

* Danish speaking
* Diagnosed with stage 3 malignant melanoma
* Eligible for adjuvant immunotherapy

Exclusion Criteria:

* Metastatic disease
* Mental impairment

Conditions2

CancerMalignant Melanoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.